News

Defeat GBM Research Collaborative – Core-By-Core Progress: Discovery Core In NBTS’ first “Expert Series” blogs in 2017, we examined the topic of neurosurgery. Now, we’ll take a look, Core-by-Core, on the progress being made by our Defeat GBM (glioblastoma) Research Collaborative. Just a few weeks ago, we provided a comprehensive update on the discoveries and advances being made by Defeat GBM (and and infographic […] August 31, 2017

Defeat GBM-Funded Research Helps Reveal Another Astonishing Trick Brain Tumors Play Summary: A surprising, counter-intuitive discovery by Defeat GBM Research Collaborative-funded researchers opens up a potential new approach to slowing glioblastoma (GBM) growth We all learn during grade school math that when doing multiplication, “a negative times (x) a negative equals a positive.” Could this be true for glioblastoma tumor biology, too? A new study from […] May 12, 2017

National Brain Tumor Society Funding and Support of Innovative Research Helps Bring About an Immunotherapy Clinical Trial With Encouraging Results Today, encouraging results from a small, early-stage clinical trial for glioblastoma patients were reported in the scientific and medical journal, Clinical Cancer Research. The phase one study of 11 newly diagnosed glioblastoma (GBM) patients showed that combining an experimental immunotherapy with chemotherapy (temozolomide), along with an injection to prime the immune system, was well tolerated […] April 14, 2017

Brain Tumor Research Highlights: March 2017 > See February’s Brain Tumor Research Highlights Over the years, NBTS has given more than $35 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing the neuro-oncology field closer to better treatments and ultimately a cure. And while NBTS is currently focused on driving our flagship research […] March 30, 2017

Hiding in Plain Sight: Defeat GBM Research Collaborative Helps Produce Paradigm-Shifting Study Short Summary: Small fragments of DNA that are not part of chromosomes (where DNA is usually packaged in human cells) – which were thought to be inconsequential and extremely rare in human cancers – have been found in high-frequencies in brain tumors, but not normal cells. These circular stretches of “extrachromosomal” DNA were revealed to have […] February 8, 2017